BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38442520)

  • 1. Lactic acid responsive sequential production of hydrogen peroxide and consumption of glutathione for enhanced ferroptosis tumor therapy.
    Zou W; Gao F; Meng Z; Cai X; Chen W; Zheng Y; Ying T; Wang L; Wu J
    J Colloid Interface Sci; 2024 Jun; 663():787-800. PubMed ID: 38442520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy.
    Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S
    J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy-mediated redox homeostasis-controllable nanomedicine for enhanced ferroptosis sensitivity in tumor therapy.
    Lin Y; Chen X; Yu C; Xu G; Nie X; Cheng Y; Luan Y; Song Q
    Acta Biomater; 2023 Mar; 159():300-311. PubMed ID: 36642338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitor-enhanced nanocatalytic ferroptosis induction for stimuli-responsive dual-modal molecular imaging guided cancer radiosensitization.
    Zheng S; Hu H; Hou M; Zhu K; Wu Z; Qi L; Xia H; Liu G; Ren Y; Xu Y; Yan C; Zhao B
    Acta Biomater; 2023 May; 162():72-84. PubMed ID: 36931419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
    Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
    Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-Generated Reactive Oxygen Species Storm for High-Performance Ferroptosis Therapy.
    Huang L; Zhu J; Xiong W; Feng J; Yang J; Lu X; Lu Y; Zhang Q; Yi P; Feng Y; Guo S; Qiu X; Xu Y; Shen Z
    ACS Nano; 2023 Jun; 17(12):11492-11506. PubMed ID: 37283506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tumor microenvironment responsive nanoplatform with oxidative stress amplification for effective MRI-based visual tumor ferroptosis.
    Luo S; Ma D; Wei R; Yao W; Pang X; Wang Y; Xu X; Wei X; Guo Y; Jiang X; Yuan Y; Yang R
    Acta Biomater; 2022 Jan; 138():518-527. PubMed ID: 34775124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-Assembled Copper-Based Nanoparticles for Glutathione Activated and Enzymatic Cascade-Enhanced Ferroptosis and Immunotherapy in Cancer Treatment.
    Song WF; Zeng JY; Ji P; Han ZY; Sun YX; Zhang XZ
    Small; 2023 Aug; 19(35):e2301148. PubMed ID: 37118853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactive Iridium Nanoclusters with Glutathione Depletion Ability for Enhanced Sonodynamic-Triggered Ferroptosis-Like Cancer Cell Death.
    Nie T; Zou W; Meng Z; Wang L; Ying T; Cai X; Wu J; Zheng Y; Hu B
    Adv Mater; 2022 Nov; 34(45):e2206286. PubMed ID: 36134532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functionalized Fe-Doped Carbon Dots Exhibiting Dual Glutathione Consumption to Amplify Ferroptosis for Enhanced Cancer Therapy.
    Zhou M; Yang Z; Yin T; Zhao Y; Wang CY; Zhu GY; Bai LP; Jiang ZH; Zhang W
    ACS Appl Mater Interfaces; 2023 Nov; 15(46):53228-53241. PubMed ID: 37943281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy.
    Hu X; Li R; Wu W; Fang K; Zhu Z; Wang Y; Zhou L; Chen M; Dong C; Shi S
    J Control Release; 2022 Aug; 348():660-671. PubMed ID: 35716884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione/pH-responsive copper-based nanoplatform for amplified chemodynamic therapy through synergistic cycling regeneration of reactive oxygen species and dual glutathione depletion.
    Jia S; Ke S; Tu L; Chen S; Luo B; Xiong Y; Li Y; Wang P; Ye S
    J Colloid Interface Sci; 2023 Dec; 652(Pt A):329-340. PubMed ID: 37597414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A ferroptosis amplifier based on triple-enhanced lipid peroxides accumulation strategy for effective pancreatic cancer therapy.
    Chen M; Tong X; Sun Y; Dong C; Li C; Wang C; Zhang M; Wen Y; Ye P; Li R; Wan J; Liang S; Shi S
    Biomaterials; 2024 Sep; 309():122574. PubMed ID: 38670032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin.
    Yang XX; Xu X; Wang MF; Xu HZ; Peng XC; Han N; Yu TT; Li LG; Li QR; Chen X; Wen Y; Li TF
    J Nanobiotechnology; 2022 May; 20(1):230. PubMed ID: 35568865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy.
    Yang S; Wong KH; Hua P; He C; Yu H; Shao D; Shi Z; Chen M
    Acta Biomater; 2022 Mar; 140():492-505. PubMed ID: 34879292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocatalytic theranostics with intracellular mutual promotion for ferroptosis and chemo-photothermal therapy.
    Zhang M; Chen Y; Wang Q; Li C; Yuan C; Lu J; Luo Y; Liu X
    J Colloid Interface Sci; 2024 Mar; 657():619-631. PubMed ID: 38071811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering a synergistic antioxidant inhibition nanoplatform to enhance oxidative damage in tumor treatment.
    Zhang Q; Sun Z; Sun W; Yu B; Liu J; Jiang C; Lu L
    Acta Biomater; 2023 Mar; 158():625-636. PubMed ID: 36608895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable Metal-Organic-Framework-Gated Organosilica for Tumor-Microenvironment-Unlocked Glutathione-Depletion-Enhanced Synergistic Therapy.
    Ma Y; Su Z; Zhou L; He L; Hou Z; Zou J; Cai Y; Chang D; Xie J; Zhu C; Fan W; Chen X; Ju S
    Adv Mater; 2022 Mar; 34(12):e2107560. PubMed ID: 34902181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide-mediated regulation of mitochondrial protective autophagy for enhanced chemodynamic therapy based on mesoporous Mo-doped Cu
    Zhou Z; Gao Z; Chen W; Wang X; Chen Z; Zheng Z; Chen Q; Tan M; Liu D; Zhang Y; Hou Z
    Acta Biomater; 2022 Oct; 151():600-612. PubMed ID: 35953045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amorphous ferric oxide-coating selenium core-shell nanoparticles: a self-preservation Pt(IV) platform for multi-modal cancer therapies through hydrogen peroxide depletion-mediated anti-angiogenesis, apoptosis and ferroptosis.
    Xu Z; Li Q; Zhang C; Wang P; Xu X; Ran L; Zhang L; Tian G; Zhang G
    Nanoscale; 2022 Aug; 14(32):11600-11611. PubMed ID: 35861683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.